APC and familial pancreatic carcinoma: Treatment with angiotensin inhibitors was reported to normalize the extracellular matrix, reduce the progression of pancreatic cancer, and increase the T Cell and APC activity (Liu et al., 2017), which indicates the possibility of reshaping the TME with the assistance of FUS.